Navigation Links
Japanese Court Rules In Patients Favour Over Hepatitis C Scandal

A Japanese court has ruled that the pharmaceutical companies and the state were responsible for transmitting hepatitis C through a contaminated medical product// , and has awarded damages to nine people who had acquired the disease. The 13 plaintiffs who sued for damages were prescribed fibrinogen as well as other coagulants, between 1981 and 1988, made by the Green Cross Corp, a pharmaceutical that has closed down now.

The Osaka District Court on Wednesday, ordered the state and drug makers to pay a combined 256 million yen in damages to 9 of the 13 people who were infected after being treated with fibrinogen and other blood-clotting products. It was explained that fibrinogen was initially used very commonly to stop haemorrhaging during childbirth or surgery in the U.S. and Japan. The U.S. in 1977 had stopped using fibrinogen and issued warnings on its safety, but the Japanese regulators did not check the coagulant.

Toshitsugu Nakamoto the presiding judge had ruled that the drug maker, called then ‘Green Cross Corp’, was responsible for the nine who were infected after August 1985, as by then the risks became of the drugs had become known. He also had rejected damages for the four who unfortunately contracted the virus before the date. According to the ruling by the court, of the 13 people who were treated with fibrinogen and other blood-clotting drugs, five were awarded compensation from both the state and drug makers and four only from the drug makers.

The press report that this verdict marks the first time that a Japanese court has ruled in a series of lawsuits over the hepatitis C scandal.

'"/>




Page: 1

Related medicine news :

1. 45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis
2. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
3. Woman Tests Negative For Japanese Encephalitis: Health Minister
4. Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals
5. Schools set to offer Japanese language course
6. Girlie Needle And Thread help Japanese Men to De-Stress
7. Japanese Encephalitis Immunization Programme in India
8. Leprosy Cured People In India To Be Trained By Japanese Trust
9. Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive
10. Japanese Face High Risk Of Heart Attack And Stroke, Metabolic Syndrome to Blame
11. Japanese Scientists Develop Thought-Controlled Robotic Hands
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... Routine ... measurements are consistently correct. However, regular performance testing is often neglected because ... a solution: SmartCal™ . This innovative test substance offers a fast ...
(Date:12/4/2016)... (PRWEB) , ... December 03, 2016 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... hosted its first Swirl: A Wine Tasting Event in New York City, with ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Advanced Inc., a ... has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, ... Inc. , Jason brings extensive financial and operational leadership experience to Advanced Inc. ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 BioLineRx ... in-licensing and developing promising therapeutic candidates, presents positive Phase 2a ... the Company,s leading oncology platform at the ongoing 58th American ... San Diego, California . ... , , ...
(Date:12/5/2016)... The global  non-invasive prenatal testing market  is anticipated ... by Grand View Research, Inc. Evolution of prenatal testing in the form ... screening and invasive diagnostic testing to determine the likelihood of fetal abnormality ... forecast period. Continue Reading ... ...
(Date:12/4/2016)... -- Johnson & Weaver, LLP announces that a class action ... Holdings, Inc. (NYSE: ZBH )  securities during the ... "Class Period"). Zimmer Biomet provides musculoskeletal healthcare products ... such as knee and hip reconstructive products. ... , , ...
Breaking Medicine Technology: